Therapeutic uses of BPI protein products in humans with otitis media with effusion

Details for Australian Patent Application No. 2005202199 (hide)

International Classifications

Event Publications

2 June 2005 Complete Application Filed

23 June 2005 Application Open to Public Inspection

Published as AU-B-2005202199

23 June 2005 Corrigenda

Complete Applications Filed - Name Index Under the name Xoma (US) LLC, Application No. 2005202199, under INID (54) correct the title to read Therapeutic uses of BPI protein products in humans with otitis media with effusion.

9 August 2007 Application Accepted

Published as AU-B-2005202199

13 September 2007 Change of Name(s) of Applicant(s), Section 104

Xoma (US) LLC The name of the applicant has been changed to XOMA Technology Ltd Change of Name(s) of Applicant(s), Section 104

6 December 2007 Standard Patent Sealed

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.